PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Medical Department 1, Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.\', \'Department for Dermatology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.\', \'Department for Internal Medicine I, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.\', \'Institute of Clinical Molecular Medicine, Christian-Albrechts-Universitat zu Kiel, Kiel, Germany.\', \'Department for Pediatrics, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.\', \'Department of Rheumatology, Endokrinologikum-Gruppe, Berlin, Germany.\', \'Institute for Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.\', \'Medical Department 1, Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany Bimba.Hoyer@uksh.de.\']
?:citedBy
  • -1
?:creator
?:doi
  • e00200810.1136/rmdopen-2021-002008
?:doi
?:hasPublicationType
?:journal
  • RMD open
is ?:pmid of
?:pmid
?:pmid
  • 34880128
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.169
?:rankingScore_hIndex
  • 13
is ?:relation_isRelatedTo_publication of
?:title
  • Humoral protection to SARS-CoV2 declines faster in patients on TNF alpha blocking therapies.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all